The role of adenosine diphosphate mediated platelet responsiveness for the stability of platelet integrity in citrated whole blood under ex vivo conditions

Abstract

BackgroundPlatelets are important for effective hemostasis and considered to be involved in pathophysiological processes, e.g. in cardiovascular diseases. Platelets provided for research or for therapeutic use are frequently separated from citrated whole blood (WB) stored for different periods of time. Although functionally intact platelets are required, the stability of platelet integrity, e.g. adenosine diphosphate (ADP) mediated responsiveness, has never been thoroughly investigated in citrated WB under ex vivo conditions.ObjectivesPlatelet integrity was evaluated at different time points in citrated WB units, collected from healthy donors and stored for 5 days at ambient temperature. The analysis included the measurement of activation markers, of induced light transmission aggregometry and of purinergic receptor expression or function. Inhibitory pathways were explored by determination of basal vasodilator-stimulated phosphoprotein (VASP)-phosphorylation, intracellular cyclic nucleotide levels and the content of phosphodiesterase 5A. Fresh peripheral blood (PB) samples served as controls.ResultsOn day 5 of storage, thrombin receptor activating peptide-6 (TRAP-6) stimulated CD62P expression and fibrinogen binding were comparable to PB samples. ADP induced aggregation continuously decreased during storage. Purinergic receptor expression remained unchanged, whereas the P2Y1 activity progressively declined in contrast to preserved P2Y12 and P2X1 function. Inhibitory pathways were unaffected except for a slight elevation of VASP phosphorylation at Ser239 on day 5.ConclusionAfter 5 days of storage in citrated WB, platelet responsiveness to TRAP-6 is sufficiently maintained. However, ADP-mediated platelet integrity is more sensitive to deterioration, especially after storage for more than 2 days. Decreasing ADP-induced aggregation is particularly caused by the impairment of the purinergic receptor P2Y1 activity. These characteristics should be considered in the use of platelets from stored citrated WB for experimental or therapeutic issues.

Targeted metabolomic approach in men with carotid plaque

“…Regarding adenosine diphosphate pathway, ADP and ATP regulate platelet activation resulting in shape change, aggregation, thromboxane A2 production, and release of granule contents. ADP also causes a number of intracellular events including inhibition of adenylyl cyclase, mobilization of calcium from intracellular stores, and rapid calcium influx in platelets [ 8 , 9 ]. On the other hand, eicosanoids can stimulate or inhibit platelet reactivity [ 10 ].…”

Coumarin Derivatives Inhibit ADP-Induced Platelet Activation and Aggregation

“…Activation of the P2Y1 receptor leads to the hydrolysis of phosphoinositide and activates calcium ions to promote the formation of TXA2. Activation of the P2Y12 receptor inhibits platelet internal cyclic AMP (cAMP) activation [18][19][20]. Both of these mechanisms lead to platelet aggregation and activation of GPIIb/GPIIIa on the membrane [21,22].…”

Garlic inhibitory effect on platelet activity induced by different agonists

“…Several studies have approached platelet aggregation in response to in vitro stimulation of these agonists (9,22,37,42). The fact that platelet aggregation in vivo involves a combination of agonists, is well known.…”